Bioxytran Financial Statements From 2010 to 2025
| BIXT Stock | USD 0.09 0.01 12.92% |
Check Bioxytran financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioxytran's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bioxytran financial statements analysis is a perfect complement when working with Bioxytran Valuation or Volatility modules.
Bioxytran |
Bioxytran OTC Stock Shares Owned By Insiders Analysis
Bioxytran's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Bioxytran Shares Owned By Insiders | 65.60 % |
Most of Bioxytran's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioxytran is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 65% of Bioxytran are shares owned by insiders. This is 332.15% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Bioxytran Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioxytran's current stock value. Our valuation model uses many indicators to compare Bioxytran value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioxytran competition to find correlations between indicators driving Bioxytran's intrinsic value. More Info.Bioxytran is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioxytran's earnings, one of the primary drivers of an investment's value.About Bioxytran Financial Statements
Bioxytran shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Bioxytran investors may analyze each financial statement separately, they are all interrelated. The changes in Bioxytran's assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioxytran's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts. Bioxytran operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioxytran OTC Stock Analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.